Recent studies in glioblastomas have demonstrated that the cytokine IL-6 plays a role in enhancing glioblastoma cell survival and migratory invasion (23–26), while studies in neuroblastomas demonstrated that IL-6 and IL-1α promote cell survival by acting as protectors of these nervous system-derived cancers (31). This evidence concerns the gene IL1A and neuroblastoma.